Form 4: AngioDynamics EVP and CFO Stephen Trowbridge Reports Acquisition of Stock and Options
SEC Form 4
Stephen Trowbridge, EVP and CFO of AngioDynamics, reports the acquisition of common stock, performance rights, and stock options.
Summary
- On July 17, 2024, Stephen A. Trowbridge, EVP and CFO of AngioDynamics Inc., reported acquiring 38,953 shares of common stock representing restricted stock units.
- These restricted stock units vest in four equal annual installments starting July 17, 2025.
- Trowbridge also acquired 77,905 performance rights, each representing a contingent right to receive one share of common stock.
- The number of shares earned from these performance rights will be based on AngioDynamics' total shareholder return relative to a peer group over a three-year period, with potential adjustments.
- Additionally, Trowbridge acquired 76,458 non-qualified stock options with an exercise price of $7.40, vesting in four equal annual installments beginning July 17, 2025.
- Following these transactions, Trowbridge beneficially owns 167,854 shares of AngioDynamics common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating stock and option acquisitions by an executive, which can be seen as a positive sign of confidence, but it doesn't provide enough information to strongly skew the sentiment.
Positives
- The acquisition of stock and options by a key executive like the CFO can be seen as a positive sign, indicating confidence in the company's future performance.
- The vesting schedules for the restricted stock units and stock options incentivize long-term commitment from the executive.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for insights into management's perspective on the company's stock.
Stakeholder Impact
- Shareholders may view the executive's stock acquisition as a positive signal about the company's prospects.
- Employees may be motivated by the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 07/17/2024 | Date of transaction: Acquisition of common stock, performance rights, and stock options. |
| 07/17/2025 | First vesting date for restricted stock units and stock options. |
| 07/17/2026 | Second vesting date for restricted stock units and stock options. |
| 07/17/2027 | Third vesting date for restricted stock units and stock options. |
| 07/17/2028 | Fourth vesting date for restricted stock units and stock options. |
| 07/17/2034 | Expiration date for the non-qualified stock options. |
| 07/19/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.